These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2205115)

  • 1. Effects of doxepin on withdrawal symptoms in smoking cessation.
    Murphy JK; Edwards NB; Downs AD; Ackerman BJ; Rosenthal TL
    Am J Psychiatry; 1990 Oct; 147(10):1353-7. PubMed ID: 2205115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxepin as an adjunct to smoking cessation: a double-blind pilot study.
    Edwards NB; Murphy JK; Downs AD; Ackerman BJ; Rosenthal TL
    Am J Psychiatry; 1989 Mar; 146(3):373-6. PubMed ID: 2645796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial.
    Ornish SA; Zisook S; McAdams LA
    Arch Intern Med; 1988 Sep; 148(9):2027-31. PubMed ID: 3046542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of buspirone on withdrawal symptoms associated with smoking cessation.
    Hilleman DE; Mohiuddin SM; Del Core MG; Sketch MH
    Arch Intern Med; 1992 Feb; 152(2):350-2. PubMed ID: 1739365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled comparison of clonidine and doxepin in the treatment of the opiate withdrawal syndrome.
    Täschner KL
    Pharmacopsychiatry; 1986 May; 19(3):91-5. PubMed ID: 3523550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trial of Tegretol and Anafranil/Sinequan in alcohol abstinence symptoms].
    Borg V
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):277-8. PubMed ID: 6992341
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
    Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
    Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking by patients in a smoke-free hospital: prevalence, predictors, and implications.
    Rigotti NA; Arnsten JH; McKool KM; Wood-Reid KM; Pasternak RC; Singer DE
    Prev Med; 2000 Aug; 31(2 Pt 1):159-66. PubMed ID: 10938217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers.
    Harakas P; Foulds J
    Psychopharmacology (Berl); 2002 May; 161(3):271-7. PubMed ID: 12021830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.
    Prochazka AV; Petty TL; Nett L; Silvers GW; Sachs DP; Rennard SI; Daughton DM; Grimm RH; Heim C
    Arch Intern Med; 1992 Oct; 152(10):2065-9. PubMed ID: 1417380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
    Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE
    J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of transdermal therapy with clonidine on suppression symptoms secondary to smoking cessation].
    Cervantes Escárcega JL; Guadalajara Boo JF
    Arch Inst Cardiol Mex; 1992; 62(5):435-40. PubMed ID: 1482222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of craving and withdrawal among four combination nicotine treatments.
    Schneider NG; Cortner C; Gould JL; Koury MA; Olmstead RE
    Hum Psychopharmacol; 2008 Aug; 23(6):513-7. PubMed ID: 18438964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition.
    Dawkins L; Turner J; Hasna S; Soar K
    Addict Behav; 2012 Aug; 37(8):970-3. PubMed ID: 22503574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette craving, smoking withdrawal, and clonidine.
    Glassman AH; Jackson WK; Walsh BT; Roose SP; Rosenfeld B
    Science; 1984 Nov; 226(4676):864-6. PubMed ID: 6387913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset of response to doxepin treatment.
    Barranco SF; Thrash ML; Hackett E; Frey J; Ward J; Norris E
    J Clin Psychiatry; 1979 Jun; 40(6):265-9. PubMed ID: 376498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.